Biomarkers to Detect Endocrine Therapy Resistance

NCT06067503 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Cancer
Breast Cancer
Lobular Breast Carcinoma

Interventions

DRUG: 18F-fluorofuranylnorprogesterone
DEVICE: Liquid Biopsy
DEVICE: Positron Emission Tomography/Computed Tomography

Sponsor

University of Wisconsin, Madison